Clinical Trial Update: Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether ursodeoxycholic acid improves peritoneal function in patients with end-stage kidney disease on peritoneal dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Ewha Womans University | Conditions: End-Stage Kidney Disease | Phase 4 | Status: UNKNOWN